Skip to main content
SpringerLink
Log in
SpringerLink
Log in

CQ49. Does TSH Suppression Therapy After Surgery for Differentiated Thyroid Carcinoma Improve Survival?

  • Chapter
  • First Online:
Treatment of Thyroid Tumor

  • 1329 Accesses

Abstract

Differentiated thyroid carcinoma is thought to be a TSH-dependent tumor. TSH suppression therapy is to avoid recurrence of a differentiated carcinoma by administering an adequate dose of thyroid hormone as postoperative endocrine therapy and suppressing the secretion of TSH from the pituitary gland through its negative feedback. This CQ assessed whether this improves the prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Miyakawa M (2007) (Text in Japanese) Nihon Rinsho 65:2073–2077 (NR)

    Google Scholar 

  2. McGriff NJ, Csako G, Gourgiotis L et al (2002) Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 34:554–564 (SR<RCT>)

    Article  PubMed  CAS  Google Scholar 

  3. Hovens GC, Stokkel MP, Kievit J (2007) Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer. J Clin Endocrinol Metab 92:2610–2615 (RS)

    Article  PubMed  CAS  Google Scholar 

  4. Cooper DS, Bonny S, Ho M et al (1998) Thyrotropin suppression and disease progression patients with differentiated thyroid cancer: results from the national thyroid cancer treatment cooperative registry. Thyroid 8:737–744 (PS)

    Article  PubMed  CAS  Google Scholar 

  5. Biondi B, Filwtti S, Schlumgerger M (2005) Thyroid─hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract 1:32–40 (NR)

    Article  CAS  Google Scholar 

  6. Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142 (Others)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Breast Surgery, Tokyo Medical University, Ibaraki Medical Center, 3-20-1 Chuo, Amimachi, Inashikigun, Ibaraki, 300-0395, Japan

    Minoru Fujimori

  2. Department of Breast and Endocrine Surgery, Clinical Science, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan

    Hisato Hara

  3. Department of Thoracic and Thyroid Surgery, Tokyo Medical University, Tokyo, Japan

    Hidemitsu Tsutsui

Authors
  1. Minoru Fujimori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisato Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hidemitsu Tsutsui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Minoru Fujimori .

Editor information

Editors and Affiliations

  1. Ito Hospital, 4-3-6 Jinguumae, Shibuya-ku, Tokyo, 150-8308, Japan

    Hiroshi Takami

  2. , Department of Surgery, Kuma Hospital, 8-2-35 Shimoyamate-dori, Chuo-ku, Kobe, 650-0011, Japan

    Yasuhiro Ito

  3. Noguchi Thyroid Clinic and Hospital Foun, 6-33 Noguchinaka-machi, Beppu, 874-0932, Japan

    Hitoshi Noguchi

  4. , Department of Breast and Endocrine Surge, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-8515, Japan

    Akira Yoshida

  5. , Department of Endocrine Surgery, Tokyo Women's Medical University, 8-1 Kawada- cho, Shinjuku-ku, Tokyo, 162-8666, Japan

    Takahiro Okamoto

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Japan

About this chapter

Cite this chapter

Fujimori, M., Hara, H., Tsutsui, H. (2013). CQ49. Does TSH Suppression Therapy After Surgery for Differentiated Thyroid Carcinoma Improve Survival?. In: Takami, H., Ito, Y., Noguchi, H., Yoshida, A., Okamoto, T. (eds) Treatment of Thyroid Tumor. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54049-6_70

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54049-6_70

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54048-9

  • Online ISBN: 978-4-431-54049-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation